The Journal of Organic Chemistry
Article
stirred at 0 °C for 4 h. The reaction was quenched with 2 ml H2O and
extracted with EtOAc (5 mL × 3). The combined organic layers were
dried over anhydrous Na2SO4, filtered, and concentrated under
reduced pressure. The residue was purified by Prep-TLC (SiO2, pet.
ether/EtOAc = 3:1) to provide phenyl(quinoxalin-2-yl) methanol
(110 mg, 73.6% yield) as yellow oil.
Tert-Butyl-4-(pyridin-4-ylmethyl)piperidine-1-carboxylate (6).
Tert-Butyl-4-(pyridin-4-ylmethyl)piperidine-1-carboxylate (6) was
prepared according to the general method. The crude product was
purified by Prep-HPLC (Neu) to afford the title compound as yellow
oil (50.0 mg, 50.0% yield). 1H NMR (CDCl3, 500 MHz): δ 8.50 (d, J
= 4.5 Hz, 2H), 7.07 (d, J = 5.0 Hz, 2H), 3.95−4.15 (m, J = 4.0 Hz,
2H), 2.61−2.70 (m, 2H), 2.45−2.55 (m, 2H), 1.68−1.75 (m, 1H),
1.54−1.65 (m, 2H), 1.45 (s, 9H), 1.14−1.17 (m, 2H); 13C{1H} NMR
(100 MHz, CDCl3): δ 154.7,149.6, 149.1, 124.5, 79.3, 42.4, 37.3,
31.8, 28.4; HRMS (ESI-TOF) m/z: [M + H]+ calcd for C16H25N2O2,
277.1911; found, 277.1915.
1H NMR (400 MHz, CDCl3): δ 8.74 (s, 1H), 8.09−8.17 (m, 2H),
7.75−7.83 (m, 2H), 7.36−7.46 (m, 5H), 6.03 (s, 1H), 5.14 (br s,
1H); 13C{1H} NMR (100 MHz, CDCl3): δ 155.5, 144.3, 141.9,
141.4, 140.4, 130.5, 129.9, 129.3, 128.9, 128.8, 128.5, 127.3, 74.4;
HRMS (ESI-TOF) m/z: [M + H]+ calcd for C15H13N2O, 237.1022;
found, 237.1021.
2-(2,2,2-Trifluoroethyl) Pyridine (8). 2-(2,2,2-trifluoroethyl) pyr-
idine (8) was prepared according to the general method. The crude
mixture was purified by Prep-TLC (SiO2, pet. ether/EtOAc = 5:1) to
Phenyl(quinolin-2-yl)methanol (23). To a solution of quinoline-2-
carbaldehyde (100 mg, 0.636 mmol) in THF (2.00 mL) at 0 °C was
added phenylmagnesium bromide (0.700 mL, 0.700 mmol, 1 M in
Et2O) under N2 protection.15 Then, the reaction mixture was stirred
at 0 °C for 4 h. The reaction was quenched with 2 mL of H2O and
extracted with EtOAc (5 mL × 3). The combined organic layers were
dried over anhydrous Na2SO4, filtered, and concentrated under
reduced pressure. The residue was purified by Prep-TLC (SiO2, pet.
ether/EtOAc = 3:1) to provide phenyl (quinolin-2-yl)methanol (50.0
1
afford the title compound as colorless oil (53.0 mg, 55.0% yield). H
NMR (400 MHz, methanol-d4): δ 8.93 (d, J = 6.0 Hz, 1H), 8.65−
8.72 (m, 1H), 8.11−8.32 (q, J = 10.0 Hz 2H), 4.12−4.20 (m, 2H);
13C{1H}NMR (125 MHz, CDCl3): δ 150.7, 149.8, 137.0, 126.5,
124.6, 123.1, 42.8 (q, J = 29.1); HRMS (ESI-TOF) m/z: [M + H]+
calcd for C7H7F3N, 162.0525; found, 162.0523.
4-(2,2,2-Trifluoroethyl) Pyridine (10). 4-(2,2,2-Trifluoroethyl)
pyridine (10) was prepared according to the general method. The
crude mixture was purified by Prep-TLC (SiO2, pet. ether/EtOAc =
1:1) to afford the title compound as colorless oil (68.0 mg, 74.0%
yield). 1H NMR (500 MHz, methanol-d4): δ 8.84 (d, J = 6.0 Hz, 2H),
8.00 (d, J = 6.0 Hz, 2H), 3.95 (q, J = 10.0 Hz, 2H); 13C{1H} NMR
(125 MHz, CDCl3): δ 150.1, 138.9, 126.2, 125.1, 123.9, 39.8 (q, J =
29.2 Hz); HRMS (ESI-TOF) m/z: [M + H]+ calcd for C7H7F3N,
162.0525; found, 162.0530.
2-Benzylpyrazine (12). 2-Benzylpyrazine (12) was prepared
according to the general method. The crude product was purified
by flash chromatography on silica gel (pet. ether/EtOAc = 3:1) to
afford the title compound as yellow oil (200 mg, 46.0% yield).1H
NMR (500 MHz, CDCl3): δ 8.51 (d, J = 1.5 Hz, 1H), 8.48−8.50 (m,
1H), 8.42 (d, J = 2.0 Hz, 1H), 7.33 (t, J = 7.5 Hz, 2H), 7.25−7.29 (m,
3H), 4.18 (s, 2H); 13C{1H} NMR (100 MHz, CDCl3): δ 156.5,
144.7, 144.0, 142.3, 138.0, 129.0, 128.7, 126.7, 41.9; HRMS (ESI-
TOF) m/z: [M + H]+ calcd for C11H11N2, 171.0917; found,
171.0922.
2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)-
thiazole (14). 2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-
benzyl)thiazole (14) was prepared according to the general method.
The crude product was purified by flash chromatography on silica gel
(pet. ether/EtOAc = 3:1) to afford the title compound as yellow oil
(100 mg, 53.0% yield). 1H NMR (500 MHz, methanol-d4): δ 7.72 (t,
J = 5.0 Hz, 3H), 7.48 (d, J = 3.5 Hz, 1H), 7.33 (d, J = 8.0 Hz, 2H),
4.39 (s, 2H), 1.36 (s, 12H); 13C{1H} NMR (100 MHz, methanol-d4):
δ 170.9, 141.4, 141.0, 134.7, 127.9, 119.5, 83.6, 38.4, 23.7; HRMS
(ESI-TOF) m/z: [M + H]+ calcd for C16H21BNO2S, 302.1381; found,
302.1380.
1
1
mg, 33.4% yield) as yellow oil. H NMR (400 MHz, CDCl3) H
NMR (500 MHz, DMSO-d6): δ 8.58 (d, J = 8.0 Hz, 1H), 8.19 (d, J =
9.0 Hz, 1H), 8.06 (d, J = 8.0 Hz, 1H), 7.89 (t, J = 7.5 Hz, 1H), 7.79
(d, J = 8.5 Hz, 1H), 7.70 (t, J = 7.0 Hz, 1H), 7.52 (d, J = 7.5 Hz, 2H),
7.36 (t, J = 7.5 Hz, 2H), 7.25−7.26 (m, 1H), 6.04 (s, 1H); 13C{1H}
NMR (100 MHz, DMSO-d6): δ 163.7, 154.9, 146.5, 143.8, 143.1,
131.8, 131.3, 131.1, 128.9, 128.8, 128.1, 127.9, 127.7, 127.0, 119.8,
75.3; HRMS (ESI-TOF) m/z: [M + H]+ calcd for C16H14NO,
236.1070; found, 236.1074.
General Procedure for the Synthesis of Deoxygenated α-
Heteroaryl-Substituted Methanol Derivatives. To a mixture of
α-heteroaryl-substituted methanol derivatives (1 equiv) in THF (2
mL/100 mg) were added triphenylphosphine (1.2 equiv), imidazole
(1.5 equiv), and I2 (1.2 equiv) at 25 °C under N2 protection. Then,
the reaction mixture was stirred at the reflux temperature under N2
protection for 16 h. After cooling to room temperature, the mixture
was diluted with water and extracted by EtOAc twice. The combined
organic layers were dried over anhydrous Na2SO4, filtered, and
concentrated under reduced pressure. The residue was purified by
chromatography, Prep-TLC, or Prep-HPLC to afford the dehydroxy
product.
Synthesis of tert-Butyl-4-(pyridin-2-ylmethyl)piperidine-1-car-
boxylate (2). To a mixture of compound 1 (100 mg, 0.342 mmol)
in THF (2 mL) were added triphenylphosphine (108 mg, 0.410
mmol), imidazole (34.9 mg, 0.513 mmol), and I2 (104 mg, 0.410
mmol) at 25 °C under N2 protection. Then, the reaction mixture was
stirred at the reflux temperature under N2 protection for 16 h. The
mixture was diluted with water (5 mL) and extracted with EtOAc (10
mL × 2). The combined organic layers were dried over anhydrous
Na2SO4, filtered, and concentrated under reduced pressure. The
residue was purified by Prep-TLC (SiO2, pet. ether/EtOAc = 1:1) to
give compound 2 as yellow oil (870 mg, 92.0% yield). 1H NMR (500
MHz, CDCl3): δ 8.55 (d, J = 4.0 Hz, 1H), 7.57−7.61 (m, 1H), 7.09−
7.13 (m, 2H), 4.07−4.08 (m, 2H), 2.67−2.72 (m, 4H), 1.95−1.98
(m, 1H), 1.55−1.70 (m, 2H), 1.45 (s, 9H), 1.18−1.22 (m, 2H);
13C{1H} NMR (100 MHz, CDCl3): δ 160.1, 154.8, 149.3, 136.1,
5-Benzyl-4-Methyl-4H-1,2,4-triazole-3-thiol (16). 5-Benzyl-4-
methyl-4H-1,2,4-triazole-3-thiol (16) was prepared according to the
general method. The crude product was purified by Prep-TLC (SiO2,
EtOAc/MeOH = 100:1) to afford the title compound as a yellow
1
solid (57.0 mg, 62.0% yield). H NMR (400 MHz, CDCl3): δ 7.31−
7.38 (m, 3H), 7.18−7.20 (m, 2H), 4.06 (s, 2H), 3.39 (s, 3H);
13C{1H} NMR (100 MHz, methanol-d4): δ 151.9, 134.2, 128.6, 128.2,
123.6, 121.1, 79.2, 45.2, 36.7, 31.9, 28.4; HRMS (ESI-TOF) m/z: [M
127.0, 31.0, 29.4; HRMS (ESI-TOF) m/z: [M + H]+ calcd for
C10H12N3S, 206.0746, found 206.0750. mp: 149−151 °C.
+ H]+ calcd for C16H25N2O2, 277.1911; found, 277.1915.
Methyl-6-(cyclohexylmethyl) Picolinate (4). Methyl-6-(cyclohex-
ylmethyl) picolinate (4) was prepared according to the general
method. The crude mixture was purified by Prep-TLC (SiO2, pet.
ether/EtOAc = 3:1) to afford the title compound as yellow oil (162
mg, 87.0% yield).1H NMR (500 MHz, CDCl3): δ 7.95 (d, J = 7.5 Hz,
1H), 7.72 (t, J = 7.5 Hz, 1H), 7.27−7.30 (m, 1H), 4.00 (s, 3H), 2.77
(d, J = 7.0 Hz, 2H), 1.69−1.79 (m, 1H), 1.61−1.66 (m, 5H), 1.19−
1.23 (m, 3H), 0.99−1.18 (m, 2H); 13C{1H} NMR (100 MHz,
CDCl3): δ 166.1, 161.8, 147.6, 136.6, 126.9, 122.5, 52.8, 46.0, 38.4,
32.9, 26.4, 26.1; HRMS (ESI-TOF) m/z: [M + H]+ calcd for
C14H20NO2, 234.1489; found, 234.1485.
2-Fluoro-3-((1-((2-(trimethylsilyl)ethoxy)methyl)-1H-1,2,4-tria-
zol-3-yl)methyl) Pyridine (18). 2-Fluoro-3-((1-((2-(trimethylsilyl)-
ethoxy)methyl)-1H-1,2,4-triazol-3-yl)methyl) pyridine (18) was
prepared according to the general method. The crude product was
purified by Prep-HPLC (TFA) to afford the title compound as a white
solid (53.0 mg, 60.0% yield). 1H NMR (500 MHz, CDCl3): δ 8.14 (d,
J = 4.5 Hz, 1H), 7.85 (s, 1H), 7.72 (t, J = 8.5 Hz, 1H), 7.17−7.19 (m,
1H), 5.51 (s, 2H), 4.24 (s, 2H), 3.53−3.57 (m, 2H), 0.82−0.86 (m,
2H), 0.02 (s, 9H); 13C{1H} NMR (100 MHz, CDCl3): δ 164.0,
161.6, 154.6, 152.1, 148.1, 142.8, 123.2, 119.2 (d, J = 30.5 Hz), 68.7,
5565
J. Org. Chem. 2021, 86, 5560−5567